Cargando…
CD248: A therapeutic target in cancer and fibrotic diseases
CD248/endosialin/TEM1 is a type 1 transmembrane glycoprotein found on the plasma membrane of activated mesenchymal cells. CD248 functions during embryo development and is either not expressed or found at very low levels in adult tissues. CD248 is expressed at high levels by malignant sarcoma cells,...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398180/ https://www.ncbi.nlm.nih.gov/pubmed/30847027 http://dx.doi.org/10.18632/oncotarget.26590 |
_version_ | 1783399536280993792 |
---|---|
author | Teicher, Beverly A. |
author_facet | Teicher, Beverly A. |
author_sort | Teicher, Beverly A. |
collection | PubMed |
description | CD248/endosialin/TEM1 is a type 1 transmembrane glycoprotein found on the plasma membrane of activated mesenchymal cells. CD248 functions during embryo development and is either not expressed or found at very low levels in adult tissues. CD248 is expressed at high levels by malignant sarcoma cells, by the pericyte component of tumor vasculature and by mesenchymal cells in some fibrotic diseases. CD248 is being targeted by several experimental therapeutics including antibodies, antibody drug conjugates, as an antigen for CART cells and in therapeutic vaccines. Although the function of CD248 has yet to be fully elucidated, this protein is a potential broad scope therapeutic target. |
format | Online Article Text |
id | pubmed-6398180 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-63981802019-03-07 CD248: A therapeutic target in cancer and fibrotic diseases Teicher, Beverly A. Oncotarget Review CD248/endosialin/TEM1 is a type 1 transmembrane glycoprotein found on the plasma membrane of activated mesenchymal cells. CD248 functions during embryo development and is either not expressed or found at very low levels in adult tissues. CD248 is expressed at high levels by malignant sarcoma cells, by the pericyte component of tumor vasculature and by mesenchymal cells in some fibrotic diseases. CD248 is being targeted by several experimental therapeutics including antibodies, antibody drug conjugates, as an antigen for CART cells and in therapeutic vaccines. Although the function of CD248 has yet to be fully elucidated, this protein is a potential broad scope therapeutic target. Impact Journals LLC 2019-01-29 /pmc/articles/PMC6398180/ /pubmed/30847027 http://dx.doi.org/10.18632/oncotarget.26590 Text en Copyright: © 2019 Teicher et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Review Teicher, Beverly A. CD248: A therapeutic target in cancer and fibrotic diseases |
title | CD248: A therapeutic target in cancer and fibrotic diseases |
title_full | CD248: A therapeutic target in cancer and fibrotic diseases |
title_fullStr | CD248: A therapeutic target in cancer and fibrotic diseases |
title_full_unstemmed | CD248: A therapeutic target in cancer and fibrotic diseases |
title_short | CD248: A therapeutic target in cancer and fibrotic diseases |
title_sort | cd248: a therapeutic target in cancer and fibrotic diseases |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398180/ https://www.ncbi.nlm.nih.gov/pubmed/30847027 http://dx.doi.org/10.18632/oncotarget.26590 |
work_keys_str_mv | AT teicherbeverlya cd248atherapeutictargetincancerandfibroticdiseases |